Abstract
Establishing biobanking in cancer research is important for health research infrastructure to collect, store, process, and distribute high-quality human biological samples and associated data. The Biobank for Translational Medicine (B4MED) Unit at the European Institute of Oncology (IEO) is a landmark in this field. The aim of this analysis was to retrospectively examine the evolution of biobank activity for breast cancer research during the 10 years since the B4MED foundation.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
